Variant in the 3' region of SNCA associated with Parkinson's disease and serum α-synuclein levels.
http://www.ncbi.nlm.nih.gov/pubmed/21853288?dopt=Abstract
The effect of S129 phosphorylation on the interaction of {alpha}-synuclein with synaptic and cellular membranes.
http://www.ncbi.nlm.nih.gov/pubmed/21849493?dopt=Abstract
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.
http://www.ncbi.nlm.nih.gov/pubmed/21863007?dopt=Abstract
Phosphorylated {alpha}-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Phosphorylated {alpha}-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
http://www.pdonlineresearch.org/resources/citations/post-mortem-cerebrospinal-fluid-synuclein-levels-are-raised-multiple-system-atro
Genetic Regulation of α-Synuclein mRNA Expression in Various Human Brain Tissues
http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0007480
No comments:
Post a Comment